Randomized Trial of Tapas Acupressure for Weight Loss Maintenance (LIFE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00526565 |
Recruitment Status :
Completed
First Posted : September 10, 2007
Last Update Posted : October 5, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Obesity | Behavioral: Tapas Acupressure Technique Behavioral: Social support | Phase 2 Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 472 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Prevention |
Official Title: | Randomized Trial of Tapas Acupressure for Weight Loss Maintenance |
Study Start Date : | January 2008 |
Actual Primary Completion Date : | June 2010 |
Actual Study Completion Date : | February 2011 |

Arm | Intervention/treatment |
---|---|
Experimental: 1
TAT (Tapas Acupressure Technique)
|
Behavioral: Tapas Acupressure Technique
Practice of the TAT technique involves application of pressure to select acupoints combined with specific mental focus. The TAT pose involves lightly touching the tips of the left thumb and 4th finger to the area 1/8 inch above the inner corner of each eye and the 3rd finger to the point midway between the eyes, about ½ inch above eyebrow level. The right hand is on the back of the head, with the palm cradling the occiput and the thumb just above the hairline. Once in this position, the process is to 1) focus attention on the identified problem or behavior to be changed (e.g., over-eating); 2) focus on a positive thought related to the problem; 3) focus on the thought of healing or clearing the origins of the problem; and 4) focus on an awareness of healing or clearing any storage of the problem, at a cellular, mental, emotional, or energetic level.
Other Name: TAT |
Active Comparator: 2
SS (Professionally facilitated social support groups)
|
Behavioral: Social support
The LIFE SS maintenance intervention will consist of a series of professionally facilitated social support groups where the session content is directed by the participants. The contact hours for SS will match those of the TAT intervention. The initial SS group session will orient participants to the basics of weight maintenance, and subsequent sessions will provide opportunities for participants to share experiences and ask questions. Participants may choose to use behavioral tools as desired. In addition to the basic materials about weight loss maintenance used in both maintenance interventions, will we use the materials already used in the weight loss program for the SS group as needed. We will measure adherence by taking attendance at the SS group sessions.
Other Name: Social support groups |
- weight [ Time Frame: 18 months ]
- psychosocial measures, exercise, food frequency, and food cravings variables [ Time Frame: randomization, and @ months 12 and 18 ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 30 Years to 85 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
-
Inclusion criteria for the Phase I weight loss program:
- Men and women
- At least 30 years of age
- BMI 30-50 kg/m2 (inclusive)
- Weight <400 lbs
- Reside in Portland metropolitan area including Vancouver/Clark County, Washington
- Willing and able to participate in all aspects of the intervention
- Willing to attend the group-based weight loss program for 6 months
- Willing to follow a reduced calorie healthy dietary pattern
- Willing to exercise on a regular basis
- Willing to lose 10 pounds during the 6-month weight loss program
- Willing to accept random assignment to one of the two maintenance interventions
- Willing to provide informed consent
Exclusion criteria for the Phase I weight loss program
- Medical conditions or treatments that would be contraindicated using a diet and exercise weight loss treatment
- Treatment for cancer (except for non-melanoma skin cancer) currently or in the past 2 years
- Diabetes treated with insulin; does not exclude diet-controlled, controlled with sulfonylurea (glyburide, glipizide, etc.) with primary physician's approval, or controlled with other oral agents (metformin, precose, glitazone.)
- Psychiatric hospitalization in past 2 years
- Conditions that require limitation of physical activity
- Congestive heart failure
- Cardiovascular disease (stroke, MI, CABG, angioplasty/stent) in the past 2 years
- Taking weight loss medications currently or within past 6 months
- Any history of weight loss surgery or scheduled surgery for weight loss.
- Liposuction in the past 12 months
- Prior acupuncture or acupressure treatments for weight loss
- Planning to leave the area prior to the end of the program
- Body weight change > 20 pounds in the past 6 months
- Pregnant, breast feeding, or planning pregnancy prior to the end of participation
- Current participation in another clinical trial
- Investigator discretion for safety or adherence reasons
- Household member (living at the same address) of another participant in this study
- LIFE clinical trial staff member or family member of LIFE trial staff person

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00526565
Principal Investigator: | Charles R Elder, MD | Kaiser Permanente |
Responsible Party: | Kaiser Permanente |
ClinicalTrials.gov Identifier: | NCT00526565 |
Other Study ID Numbers: |
R01AT003928-01A1 ( U.S. NIH Grant/Contract ) R01AT003928-01A1 ( U.S. NIH Grant/Contract ) |
First Posted: | September 10, 2007 Key Record Dates |
Last Update Posted: | October 5, 2011 |
Last Verified: | October 2011 |
Weight Loss Body Weight Changes Body Weight |